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Abstract
The cell wall of Gram-positive bacteria is a complex network of surface proteins, capsular polysaccharides and wall teichoic
acids (WTA) covalently linked to Peptidoglycan (PG). The absence of WTA has been associated with a reduced pathogenicity
of Staphylococcus aureus (S. aureus). Here, we assessed whether this was due to increased detection of PG, an important
target of innate immune receptors. Antibiotic-mediated or genetic inhibition of WTA production in S. aureus led to
increased binding of the non-lytic PG Recognition Protein-SA (PGRP-SA), and this was associated with a reduction in host
susceptibility to infection. Moreover, PGRP-SD, another innate sensor required to control wild type S. aureus infection,
became redundant. Our data imply that by using WTA to limit access of innate immune receptors to PG, under-detected
bacteria are able to establish an infection and ultimately overwhelm the host. We propose that different PGRPs work in
concert to counter this strategy.
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Introduction
The complex cell surface of bacteria has been directly or
indirectly associated with different strategies that bacterial
pathogens use to interact with the host. These include acquisition
of specific adhesion factors, formation of biofilms, adaptation to an
intracellular environment, production of a protective capsular
polysaccharide or evasion of innate immune defences (e.g.
lysozyme) [1]. The host counters these strategies by targeting
conserved molecules (pathogen associated molecular patterns or
PAMPs), unique in bacteria, that are either present at the bacterial
surface or are released by bacteria as they attempt to establish
infection. Bacterial PAMPs include Peptidoglycan (PG), a
heterogeneous polymer of glycan chains cross-linked by short
peptides of variable length and amino acid composition [2].
Although PG recognition is essential to trigger an inflammatory
response, this macromolecule may not be easily accessible for
recognition at the surface of bacteria.
In Gram-positive bacteria, PG is buried within a complex cell
surface consisting of different molecules [3–5]. Such molecules
include surface proteins, covalently linked or tightly associated
with PG, capsular polysaccharides, usually required for the ability
of different bacteria to cause disease [6] and wall teichoic acids
(WTA), phosphate-rich glycopolymers involved in the resistance of
bacteria to environmental stress and regulation of bacterial
division [7]. It is not clear therefore, how the host would be able
to sense bacterial PG buried within such complex structures. One
hypothesis is that the innate immune system recognises soluble PG
fragments that are released from the bacterial cell surface through
the activity of enzymes produced by bacteria (such as autolysins) or
by the host (such as lysozyme) [2,8]. However, certain bacteria
have the ability to modify their PG, turning it more resistant to the
action of such enzymes [9], thus preventing the release of small
soluble fragments capable of triggering an innate immune
response in the host. This may be the case for Listeria monocytogenes
that has the ability to de-N-acetylate its PG allowing them to
survive the action of lysozyme and evade the host innate immune
system [10]. Another hypothesis is that the components of the host
innate immune system are able to bind directly to PG present
within the bacterial cell surface. As discussed earlier, PG is
decorated with a variety of large molecules that may sterically
block access of host receptors to the underlying PG. In Gram-
positive bacteria, cell wall glycopolymers, including WTA may
play this role [1]. The role of WTA protecting the PG from
recognition would have important implications regarding the onset
of infection by major human pathogens such as Staphylococcus aureus
(S. aureus) [1]. Recently, it has been shown that different
components, present at the cell wall of S. aureus bacteria, may
determine the survival of infected Drosophila. Specifically, S. aureus
strains impaired in the expression of enzymes involved with the
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Moreover, it has been proposed that D-alanylation of the WTA
produced by S. aureus may inhibit the recognition of PG by host
receptors. This inhibitory effect was observed in vitro not only when
WTA was covalently attached to polymeric PG but, surprisingly,
also when WTA was covalently attached to monomeric PG [12].
The fruit fly Drosophila melanogaster recognises Gram-positive
bacteria by either direct binding to PG or its smallest components
[13]. Based on in vitro data [14] and infection studies of mutants
[14,15], the current working hypothesis is that a flexible system of
pattern recognition receptors (PRRs) can be deployed by the host
immune system to detect Lysine-type PG from different Gram-
positive bacterial pathogens. Two Peptidoglycan Recognition
Proteins (PGRPs), namely PGRP-SA and PGRP-SD are major
components of this system [15,16]. Depending on the bacterium,
each, or both of these PGRPs – along with Gram-Negative
Binding Protein1 (GNBP1) [17] – interacts with PG and activate a
downstream proteolytic cascade, which culminates in Toll
receptor signalling. The signal reaches the cytoplasmic NF-kB/I-
kB complex via a receptor/adaptor complex comprising dMyD88,
Tube and the IRAK homologue Pelle. At that point the I-kB
homologue Cactus is phosphorylated and targeted for degradation
while the NF-kB homologue Dif is free to enter the nucleus of host
cells and regulate target genes [18]. Prominent among these genes,
is a group of potent antimicrobial peptides (AMPs), which are
synthesised by the fat body and secreted into the haemolymph. An
AMP frequently used as a read-out for the Toll pathway is
Drosomycin (Drs). AMPs and local melanization, along with the
phagocytic activity of haemocytes constitute respectively the
humoral and cellular arm of the fruit fly response to infection [18].
Here, we report for the first time that Drosophila PGRP-SA, a
non-lytic PGRP was able to bind intact live bacteria in vivo. Access
to PG was limited by the presence of WTA: binding of PGRP-SA
to various live Gram-positive bacteria was minimal, but binding to
purified PG, stripped of covalent modifications (including WTA)
was far greater. Through inhibiting WTA synthesis, either by the
addition of an antibiotic or genetically, we were able to potentiate
detection of these bacteria by PGRP-SA. For S. aureus, this
correlated with a reduced ability of the bacteria to proliferate
within the host, and a reduced susceptibility of the host to infection
in a PGRP-SA/GNBP1 dependent manner. We also observed
that PGRP-SD, essential for sensing wild type S. aureus, became
redundant as WTA levels were reduced. Overall, our results
suggest that WTA may be part of a general mechanism used by
Gram-positive bacteria, which limits the access of innate receptors
to PG, thereby enabling bacteria to evade detection and establish
infection.
Results
To address the question of whether Gram-positive bacteria
counter host recognition by limiting access of innate sensors to PG,
we constructed a fluorescent derivative of the fruit fly Lys-type PG
receptor, PGRP-SA (mCherry-PGRP-SA). This construct and an
untagged version (rPGRP-SA) were expressed in Escherichia coli and
the resulting proteins were purified. As shown in the supplemen-
tary material (Figure S1A), injection of mCherry-PGRP-SA, or
rPGRP-SA, into PGRP-SA deficient flies restored Drs-GFP
production induced by infection with Micrococcus luteus (M. luteus).
Endogenous Drs expression was also restored as confirmed by
qPCR (Figure S1B). These observations were consistent with our
previous results when using a recombinant PGRP-SA expressed in
the lepidopteran cell line Sf9 [19]. Taken together, these results
showed that the fluorescently tagged PGRP-SA and the untagged
versions are functional and capable of restoring an innate immune
response in PGRP-SA deficient flies.
Initially, we used rPGRP-SA and mCherry-PGRP-SA in co-
precipitation experiments in order to study binding to PG from
different Gram-positive bacteria. Both bound with similar affinity
to PG purified from M. luteus, Enterococcus faecalis (E. faecalis), and S.
aureus (data not shown and Figure 1A, respectively). For details of
PG composition of these bacteria see Figure S2. Importantly, this
indicated that the mCherry-tag appeared not to interfere with
PGRP-SA binding, and thus, demonstrated that both proteins
were able to bind Lys-type PG of different composition. We
therefore assessed in vitro, the binding of mCherry-PGRP-SA to the
surface of live bacteria harvested during exponential growth phase.
Notably, the binding of the recombinant protein to live bacteria
exhibited a range of different affinities in contrast to their
respective purified PG. Binding to live E. faecalis and S. aureus
was significantly reduced, when compared to binding to M. luteus
(Figure 1B). However, the binding levels of PGRP-SA to the
purified PG from these bacteria were similar (Figure 1A). We also
noticed that while mCherry-PGRP-SA was capable of binding the
entire surface of M. luteus cells, it bound at specific sites at the
surface of S. aureus cells, similar to what has been described
recently for mammalian bactericidal PGRPs [20]. These results
suggested that although the three types of bacterial PG were
similarly recognized by PGRP-SA, the presence of other
components found at the surface of live bacteria might have
prevented PGRP-SA from finding its PG ligand.
The cell surface of a Gram-positive bacterium is a complex
structure consisting of a thick layer of PG, surface proteins and
glycopolymers such as capsular polysaccharides and WTA. As
previous studies had shown that certain PG-binding proteins, such
as bacterial autolysins, have a higher affinity for the surface of
bacterial strains lacking WTA [21–23], it was decided to
investigate whether presence of WTA could be preventing
PGRP-SA from binding to the surface of live bacteria. Further
support for the choice of WTA came from the fact that different
Gram-positive bacteria can produce WTA with a variable
composition [24–26]. M. luteus, for which mCherry-PGRP-SA
Author Summary
Gram-positive bacteria such as the opportunistic pathogen
Staphylococcus aureus have their cell wall exposed to the
environment found within a host. Following an infection
these bacteria need to find ways to evade or reduce
recognition by the host in order to survive and potentially
proliferate. The cell wall of Gram-positive bacterium
consists of an intricate network of glycan chains cross-
linked by short peptides called peptidoglycan (PG; a major
target for host recognition in a variety of animals)
covalently linked to surface proteins and glycopolymers
including Wall Teichoic Acids (WTA). It has been proposed
that lack of WTA reduce the pathogenicity of S. aureus.W e
asked whether this was due to better recognition of PG.
We found that both bacterial recognition and survival of
fruit flies (our model host) infected with bacteria lacking
WTA was markedly increased compared to those infected
with wild type S. aureus. This result was quantifiable: a
reduction in the amount of WTA resulted in greater
binding by host receptors and a higher host survival. We
propose that the presence of WTA limit access to PG and
therefore reduce the recognition ability of the host.
Bacteria are thus able to increase in numbers and
eventually overwhelm the host.
Wall Teichoic Acids Limit Host Recognition
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(Figure S2C). To test whether WTA mediated the differential
binding of PGRP-SA, we cultured bacteria in the presence of
tunicamycin, thereby inhibiting their ability to synthesize WTA.
At lower, sub-inhibitory concentrations as those used in this study,
tunicamycin specifically inhibits TagO [28]: a glycosyltransferase
that specifically localizes to the division septum of S. aureus [29]
and is required for the initial step of WTA biosynthesis, namely,
the transfer of GlcNAc to the C55-P lipid anchor bactoprenol. We
observed higher levels of mCherry-PGRP-SA binding to the newly
synthesized cell material, located at the division septum, when
Gram-positive bacteria cells were treated with tunicamycin
(Figure 2A). S. aureus and S. saprophyticus exhibited a similar
increase in binding, 636 and 846 respectively, whilst E. faecalis
binding increased 86. It should be noted that the effect of
tunicamycin in these bacteria was not the same. While addition of
the antibiotic resulted in binding of mCherry-PGRP-SA to the
entire cell surface of S. aureus, binding was observed predominantly
at the division septum in S. saprophyticus and exclusively at this
region in E. faecalis. We attribute these differences to how and
where the new cell wall synthesis occurs in these bacteria.
Figure 1. Differential binding of PGRP-SA to the surface of live
Gram-positive bacteria. (A) PGRP-SA and PG co-precipitation assay.
Lys-type PG from M. luteus, E. faecalis, S. aureus, and DAP-type PG from
B. subtilis (this acts as a negative substrate control for PGRP-SA binding,
which recognizes Lys-type PG), was incubated with rPGRP-SA for 30
minutes. Unbound rPGRP-SA remained in the supernatant fraction
upon centrifugation (S). rPGRP-SA bound to the insoluble PG was co-
precipitated and found in the pellet fraction (P). Quantified data
(performed using ImageJ software) was plotted as mean values with
95% confidence limits: very little co-precipitation of rPGRP-SA occurred
in the absence of PG (labelled Control) or in the presence of B. subtilis
DAP-type PG; however, PGRP-SA was co-precipitated similarly (One-way
ANOVA, P.0.05) and at higher levels with the PG from M. luteus, E.
faecalis,o rS. aureus. The data shown (mean with 95% confidence
intervals) was obtained from 4 independent co-precipitation experi-
ments. (B) mCherry-PGRP-SA was incubated with bacteria cells
harvested in exponential phase, washed with PBS and visualized using
fluorescence microscopy. Grey panels are phase-contrast images of
bacterial cells (white scale bar represents 1 mm), and black panels
mCherry-PGRP-SA binding: white arrowheads highlight binding to the
lateral cell surface or the region of cell division. The total fluorescence of
mCherry-PGRP-SA bound to a bacterium (covering all lateral and cell
division regions, and including background) was quantified for each
species (n=50), and represented as the median (with 25% and 75%
inter-quartile range). Dashed-line indicates the level of the background
signal, control. Kruskal-Wallis analysis with Dunn’s multiple comparison
post-test did not reveal significant differences (P.0.05) between
mCherry-PGRP-SA binding to E. faecalis and B. subtilis, which were
indistinguishable from the control. However, the protein bound more
to S. aureus and M. luteus relative to the control, with the latter
exhibiting highest binding (P,0.05 in all cases).
doi:10.1371/journal.ppat.1002421.g001
Figure 2. WTA reduce PGRP-SA binding at the bacterial cell
surface. Grey panels are phase-contrast images of bacterial cells (white
scale bar represents 1 mm), and black panels mCherry-PGRP-SA binding;
white arrowheads highlight binding to the lateral cell surface or region
of cell division. The binding of mCherry-PGRP-SA to individual bacterial
cells (n=50) was quantified, and represented as the median (with 25%
and 75% inter-quartile range). (A) mCherry-PGRP-SA binding to Gram-
positive bacteria grown with or without tunicamycin, an inhibitor of
WTA synthesis. mCherry-PGRP-SA binding to the cell division region,
rather than total binding, was measured because binding at the former
was consistently enhanced for all treated bacteria species. Mann-
Whitney U tests were used to compare differences for treated and
untreated between each type of bacteria (P,0.05 in all cases). (B)
RNDtagO mutant background rescued with variants of the tagO gene –
expressed from a replicative pMAD vector – produce varying levels of
WTA, given as a% relative to the wild type RN4220: pMAD vector (0%),
ptagO (90%), ptagOD87A/D88A (0%), ptagOG152A (22%). Total binding
of mCherry-PGRP-SA to the surface of live bacteria increases as the
levels of WTA are reduced. Kruskal-Wallis analysis followed by Dunn’s
multiple comparison post-test, revealed significant differences for all
comparisons (P,0.05) except for that between PGRP-SA binding to
pMAD and ptagOD87A/D88A.
doi:10.1371/journal.ppat.1002421.g002
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different bacteria might protect PG from exposure to host
receptors.
To confirm that WTA were indeed required to reduce access of
PGRP-SA at the cell surface, we quantified the binding of
mCherry-PGRP-SA to S. aureus mutants that produced varying
amounts of WTA due to mutations in the tagO gene [29]. We
chose S. aureus because it is a major human pathogen with a well-
characterised WTA synthetic pathway [30,31]. A complete
absence of WTA, which occurs when tagO is entirely deleted
(RNDtagO pMAD), or when two highly conserved residues have
been mutated (RNDtagO ptagO
D87A/D88A), resulted in equivalently
enhanced levels of mCherry-PGRP-SA binding, when compared
to the wild type strain (,2610
3 and ,3.3610
3-fold respectively,
Figure 2B). To verify that the observed result was indeed due to
the loss of WTA, we expressed wild type tagO in the RNDtagO
background (RNDtagO ptagO): this rescued the loss of WTA (WTA
levels restored to 90% of wild type levels) [29], and reduced
mCherry-PGRP-SA binding to levels close to those observed for
the wild type strain (Figure 2B). A tagO mutant that could only
support production of a reduced amount of WTA (RNDtagO
ptagO
G152A; 24% levels of WTA compared to wild type) exhibited
an intermediate level of mCherry-PGRP-SA binding relative to all
strains (6610
2-fold increase relative to the wild type strain,
Figure 2B). Overall, our data indicated that WTA found in the cell
wall of different live Gram-positive bacteria restricted PGRP-SA
from binding their PG, and in S. aureus this occurs in a dose
dependent manner.
We next wanted to examine whether increased PGRP-SA
binding – due to a lack of WTA – affected the ability of bacteria to
survive in an in vivo system. We chose D. melanogaster because it is a
well-established model for dissecting pattern recognition in innate
immunity [18]. We know for example that in vitro, three PRRs –
PGRP-SD/PGRP-SA/GNBP1 – form a ternary complex for
binding to the PG of S. aureus [14]. As a first approach wild type
and mutant S. aureus strains were injected into wild type flies and
also into flies defective for PGRP-SD or PGRP-SA. We then
determined the number of CFUs 6 and 17 hours post-infection;
the latter time point being when the first flies succumb to infection
(Figure 3 and S5). All flies were inoculated with low and
statistically identical numbers of bacteria (,10
2 CFUs per fly;
Figure 3, Time 0). Our rationale was to induce infections that were
comparable and that could evolve over time. For example, flies
generally succumb to bacterial infection when their numbers
increase beyond 10
6 CFUs per fly [18,32], and therefore, high
initial loads (e.g. 10
4–10
5 CFUs per fly) may overwhelm the host
and consequently may not be informative regarding the course of
an infection. We observed that wild type S. aureus (NCTC8325-
4) CFUs increased in all fly backgrounds over the period of
infection to numbers that were statistically separable, with PGRP-
SA deficient flies carrying the heaviest load (Figure 3). In contrast,
the numbers of the S. aureus mutant, which lacked WTA
(NCTCDtagO) [29], did not significantly increase in the wild type
or PGRP-SD mutant background. However, the number of
NCTCDtagO bacteria in the PGRP-SA mutant was significantly
higher at both the 6 and 17 hours time points (Figure 3). Two-way
ANOVA revealed a significant interaction between the bacteria
and fly strains, which was due to the large increase of NCTCDtagO
bacteria in the PGRP-SA mutant. Together, these data indicated
that WTA were fundamental for S. aureus to counter recognition by
PGRP-SA, and consequently, the bacteria were able to increase
their number during the initial course of infection.
We have previously observed that PG produced by
NCTCDtagO bacteria has reduced levels of cross-linking relative
to the wild type strain [29]. To evaluate whether this contributed
to the inability of NCTCDtagO bacteria to increase their number
in wild type or PGRP-SD mutant flies, we assessed mCherry-
PGRP-SA binding to NCTCDpbpD and determined CFUs at 6
and 17 hours. NCTCDpbpD is a derivative of NCTC8325-4 in
which pbpD (the gene encoding to penicillin binding protein 4,
PBP4) has been deleted. Deletion of pbpD results in a strain that
produces PG with a similar level of cross-linking to that found in
NCTCDtagO [29], but which still produces WTA. The inability of
NCTCDpbpD and NCTCDtagO to produce a highly crosslinked
PG did not interfere with bacteria growth in culture, as its
duplication time at 30uC was very similar to the parental
NCTC8325-4 strain (Figure S3B). In both experiments,
NCTCDpbpD behaved as the wild type bacteria. Firstly, binding
mcherry-PGRP-SA similarly (Figure S3C) and secondly, for each
fly background attaining numbers that were statistically insepara-
ble from those for NCTC8325-4 (Figure 3, Time +17 hours).
To assess whether the developing trend in bacterial numbers at
17 hours post-infection resolved into differences in how flies
survive, we monitored the number of flies alive at 24 hour
intervals over 3 days. In addition, we infected GNBP1 mutant flies,
because GNBP1 has been postulated to work as part of a complex
with PGRP-SA [14,17]. Survival curves for a particular fly
background when infected with either NCTC8325-4 or
NCTCDpbpD were statistically inseparable, except for those
obtained for the wild type background, where flies succumbed
more to NCTCDpbpD (Figure 4; 62% and 38% survival at
72 hours post-infection, respectively). Nearly all PGRP-SA and
GNBP1 mutant flies had died by 24 hours, whereas ,40% of
PGRP-SD mutant flies survived beyond this time point,
succumbing to infection around 48 hours (,5% of flies surviving).
In contrast, ,95% of wild type and PGRP-SD mutant flies
survived the NCTCDtagO infection up to 72 hours (furthermore,
taking CFUs at this time-point revealed that NCTCDtagO had
been eliminated from these flies, 0 CFUs per fly). The majority of
PGPR-SA and GNBP1 flies had succumbed to infection by
48 hours (3% of flies surviving). A similar trend in survival
outcome was observed with NCTC8325-4 after treatment with
tunicamycin (Figure 4). These data confirmed that WTA were
indeed required to counter host immunity, because without them,
infection could be controlled in a PGRP-SA/GNBP1 dependent
manner. Differences in CFUs were apparent 6 hours post-
infection suggesting that recognition and reduction of propagation
or killing of bacteria, occurs rapidly following infection. Interest-
ingly, these results also showed that a requirement for PGRP-SD
was bypassed when WTA are removed and PGRP-SA has far
greater access to PG.
To further demonstrate the necessity for WTA to protect PG
from host recognition, we monitored survival of flies infected with
the aforementioned TagO point mutations (Figure 2B and
Figure 5). In these experiments, we wanted to rule out unknown
causes that may occur due to the absence of the TagO protein per
se, and also, lessen adverse effects that may occur due to a
complete lack of WTA. The survival trend for flies infected with
RNDtagO pMAD, that lacks tagO and carries an empty pMAD
plasmid vector (vector control), was similar to that for
NCTCDtagO: the PGRP-SA mutant succumbed rapidly, whereas
the PGRP-SD mutant and wild type flies generally survived, their
curves being statistically inseparable (Figure 5). The injection of
the complemented strain (RNDtagO ptagO) resulted in survival
outcomes that were characteristic of NCTC8325-4, with PGRP-
SD mutant and wild type flies succumbing to the infection, with
their curves being statistically separated (Figure 5). Notably, wild
type and PGRP-SD mutant flies infected with RNDtagO
Wall Teichoic Acids Limit Host Recognition
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G152A (which produces ,24% WTA relative to RNDtagO
ptagO but produces similar levels of the TagO protein) [29]
survived to intermediary levels (Figure 5). Overall, survival of wild
type flies decreased as WTA levels increased (with a concomitant
decrease in PGRP-SA binding, Figure 2B), and likewise for the
PGRP-SD mutant; with the difference between wild type and
PGRP-SD mutant survival successively increasing. In contrast,
survival of PGRP-SA mutant flies was independent of WTA levels,
with flies succumbing strongly for all infections in a statistically
inseparable manner (Figure 5). These data confirmed that it was
indeed in vivo protection of PG by WTA against the consequences
of PGRP-SA binding, and furthermore, suggested that a
requirement for PGRP-SD gradually became redundant as
WTA levels decreased.
It has been reported previously that D-alanylation of WTA is
also required for the pathogenicity of S. aureus [11]; D-alanylation
Figure 3. PGRP-SA is fundamental for controlling bacterial numbers in flies infected with a S. aureus mutant that lacks WTA. Wild
type flies, and those lacking PGRP-SD or PGRP-SA, were infected with different S. aureus strains: NCTC8325-4 is the wild type; NCTCDpbpD is a mutant
that produces WTA but has a PG similar to NCTCDtagO, both exhibiting reduced cross-linking; NCTCDtagO lacks WTA. The table gives the mean CFUs
per fly (from 3 independent experiments). For each time point, the CFUs per fly data set was transformed via a Box-Cox transformation (which returns
a l number, where data-point = data-point
l –1 / l) and represented as means with 95% confidence intervals. Flies were inoculated with a low
(,100 CFUs per fly) and comparable number of bacteria (Time 0; Two-way ANOVA did not reveal significant differences, P.0.05), and CFUs per fly
were determined at 6 and 17 hours post-infection. In contrast to NCTC8325-4 and NCTCDpbpD, the number of NCTCDtagO bacteria did not
significantly increase in the wild type or PGRP-SD mutant background during the period of infection (Table); however, in the PGRP-SA mutant the
number of bacteria increased significantly for all strains (P,0.05, Repeated Measures One-way ANOVA). Two-way ANOVA of the CFUs data at Time
+17 hours revealed a significant interaction (P,0.05) between the bacteria and fly strains, which was due to the large increase of NCTCDtagO CFUs in
the PGRP-SA mutant, whilst differences in CFUs were similar for NCTC8325-4 and NCTCDpbpD. One-way ANOVA and 95% Tukey’s HSD intervals were
used to look for factor differences at this time. For each fly background NCTC8325-4 and NCTCDpbpD CFUs were equivalent (P.0.05). NCTCDtagO
CFUs in the wild type and PGRP-SD backgrounds were similar (P.0.05), but separated from all other values (P,0.05). In the PGRP-SA mutant,
NCTCDtagO CFUs reached levels seen with the other bacteria in wild type and PGRP-SD flies. The negative error bars for the NCTCDtagO infection
occur because of large variation of the biological repeats. This is consistent with the fact that NCTCDtagO occasionally causes a lethal infection in
both the wild type and PGRP-SD backgrounds.
doi:10.1371/journal.ppat.1002421.g003
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ribitol-phosphate backbone of WTA, thereby reducing the
negative charge of the polymer [33]. We examined therefore,
whether a S. aureus mutant that lacks the D-alanylation pathway
(RNDdltABCD) bound mCherry-PGRP-SA equivalently to
RNDtagO. Binding of, mCherry-PGRP-SA to RNDdltABCD was
similar to the binding to the wild type bacteria (Figure S3). This
prompted us to assess how RNDdltABCD affected survival of the
wild type, PGRP-SD and PGRP-SA mutant flies. In contrast to
RNDtagO, PGRP-SA mutant flies did not succumb strongly to
RNDdltABCD infection, with 83% surviving at 72 hours post-
infection (Figure S4); furthermore, survival was statistically
inseparable for the different fly backgrounds (Figure S4). These
data demonstrated that D-alanylation is not necessary for WTA to
limit the access of PGRP-SA, that neither PGRP-SD nor PGRP-
SA were required to control the RNDdltABCD infection and
consequently, the reduced killing effect of RNDdltABCD had
nothing to do with recognition.
Discussion
The results shown here indicate that in respect to Gram-positive
bacteria, where the cell wall is not concealed by outer membrane
(e.g. staphylococci), pathogen recognition, via recognition of PG, is
tightly linked to host survival. Our studies bring forward the notion
that one of the strategies used by pathogens to reduce recognition
is to restrict accessibility to inflammatory non-self components of
the cell wall. Specifically, the results here show that presence of
WTA in a range of Gram-positive bacteria impaired PGRP-SA
binding. The use of tunicamycin to abolish WTA synthesis
dramatically improved receptor recognition of bacteria as well as
host survival of flies infected antibiotic treated S. aureus. Genetically
Figure 4. PGRP-SA and not PGRP-SD is required to control infection by S. aureus mutant lacking WTA. Flies assayed for survival were
injected concurrently with those for determining CFUs. The survival of infected flies (n=90) was monitored at 24-hour intervals for three days, and
estimates of survival plotted (for clarity, 95% confidence intervals have been omitted). For each fly background – except wild type – survival curves
were statistically inseparable for flies infected with NCTC8325-4 or NCTCDpbpD (log-rank test, P.0.05). PGRP-SD, PGRP-SA and GNBP1 mutant flies
succumbed strongly to infection by 72 hours, whereas wild type survived up to ,60%. In contrast, wild type and PGRP-SD mutant flies were barely
susceptible to infection with NCTCDtagO, however, PGRP-SA and GNBP1 flies succumbed strongly; a similar survival trend was seen when flies were
infected with tunicamycin-treated NCTC8325-4 (GNBP1 mutant flies were not infected for this experiment).
doi:10.1371/journal.ppat.1002421.g004
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three days, and estimates of survival constructed from the raw data. Flies were infected with S. aureus mutants that produce different levels of WTA
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aureus also increased PGRP-SA binding leading to increased host
survival. It should also be noted that, rPGRP-SA was capable of
binding in vitro significantly better to WTA-free PG than to WTA-
linked PG that were purified from wild type S. aureus bacteria,
treated with trypsin to remove any attached surface proteins and
adjusted to the same concentration of PG (Figure S2). This
observation confirmed the results obtained with live bacteria and
allowed us to eliminate the notion that deletion of tagO gene may
influence the amount of protein present at the cell surface and that
this change in protein levels was influencing the binding of PGRP-
SA. Effectively during the course of this work we have removed
WTA from PG by treatment with antibiotic, by deletion of the
tagO gene and finally we have chemically removed them from PG.
In all the cases binding of PGRP-SA to PG has increased.
S. aureus produces WTA composed of about 40 ribitol
phosphate-repeating units modified with N-acetylglucosamine
(GlcNAc) and D-alanine [7]. The latter modification is mediated
by the D-Alanine ligase DltA and partially neutralizes the negative
charge of the cell surface thus reducing attraction of cationic
AMPs [33]. DdltA mutants are more susceptible to killing by
cationic AMPs and neutrophils in vitro and have markedly reduced
virulence in several animal infection models including Drosophila
[11,34]. In one of these studies [11], Tabuchi and colleagues
showed that S. aureus producing WTA without D-alanylation were
impaired in their ability to kill Drosophila. Surprisingly, the DdltA
mutant was more impaired in the ability to kill flies than an
independently generated tagO mutant [11]; the latter according to
the authors had the same pathogenicity as wild type S. aureus [11],
contrary to our findings.
There is a crucial point to be made in reference to this however,
which is at the heart of our experimental design and gives
physiological relevance to our results. We propose that WTA are
important to reduce S. aureus recognition by the host and thus help
the pathogen increase its numbers inside the fly. The host uses
PGRP-SA to control bacterial numbers and the more PGRP-SA
binds to the cell wall (see Figure 2B) the more the bacterial load is
controlled (as seen by comparing CFUs between wild type
NCTC8325-4 S. aureus and NCTCDtagO in Figure 3A). In
PGRP-SA mutants the control mechanism is absent and
NCTCDtagO was able to proliferate and kill the host (Figure 3B).
We were able to observe this because we started from a low
bacterial load (10
2 cells/initial infection/fly) and followed the
progress of pathogen load inside the host. Tabuchi et al. injected
10
4–10
6 cells per fly for all bacterial strains used [11]. In our hands
this concentration overwhelmed the host from the beginning and it
is not surprising that these authors were unable to resolve statistical
differences in host survival.
In order to rule out possible pleiotropic effects produced by the
inactivation of the tagO due to the insertion of non-replicative
plasmids or reversion of the mutation by elimination of the
plasmid from the chromosome, we have specifically deleted the
tagO gene in a manner that left no resistance marker in the
bacterial chromosome and thus minimized possible alterations on
the transcription of neighbouring genes. Finally, in order to
increase the confidence of our results, we have complemented the
tagO null mutant with plasmids that allowed the expression of a
partially active (TagO
G152A), TagO protein and have statistically
analyzed the estimated host survival probability curves obtained.
Finally we should emphasize that deletion of the tagO gene in
NCTC8325-4 strain (an agr positive strain) and in RN4220 (an agr
negative strains) resulted in similar outcomes (Figure S3) - a
reduced pathogenicity in the Drosophila infection model and the
production of a bacterial cell surface that was better recognized by
mCherry-PGRP-SA.
In parallel experiments we have also generated a DdltA deletion
mutant (this study) as well as a deletion of the DdltA operon
(DdltABCD) [29] and found that both were indeed less pathogenic
than wild type S. aureus (Figure S4), similar to what was previously
reported [11]. However, this reduced pathogenicity was also
observed in PGRP-SA and PGRP-SD single mutant flies (in
contrast to DtagO). This indicated that the non-pathogenicity of
DdltA was not linked to recognition by PGRP-SA or PGRP-SD.
We propose that increased ‘‘visibility’’ of PG to PGRP-SA when
WTA were removed, dramatically improved survival of the host.
However, alternative interpretations of our results may exist. In
the following section we will attempt to challenge and rule them
out:
1. We have recently reported that removal of WTA has an impact
on PG cross-linking and consequently on the susceptibility to
host lysozyme [29]. The possibility that the increased host
survival may be the result of decreased pathogen resistance to
the lysozyme constitutively expressed in the fly (due to the
reduced PG cross-linking in the S. aureus tagO null mutant)
rather than removal of a physical entity (WTA), which blocked
access to PG, was ruled out as follows. We generated an S.
aureus mutant unable to produce high-level PG cross-linking but
capable of producing regular levels of WTA, by deleting the
pbpD gene [29]. The pbpD gene encodes to PBP4 which is
responsible for the final stages of PG maturation and results in
highly cross-linked PG. As shown in Figure 4, bacteria that
produce PG with a low level of cross-linking, but normal levels
of WTA, were able to kill wild type flies similarly to the
parental S. aureus strain. In addition, similar amounts of
mCherry-PGRP-SA bound to the surface of both wild type
bacteria and NCTCDpbpD (Figure S3C). These results indicate
that in DtagO increased recognition by mCherry-PGRP-SA and
the inability to kill flies is due to the absence of the WTA and
not due to modifications in PG cross-linking.
2. The hypothesis that the absence of teichoic acids could turn S.
aureus bacteria more susceptible to enzymes present in the
haemolymph of Drosophila, such as lysozyme-like enzymes,
which would make the bacteria unable to kill flies, was also
considered and ruled out. In accordance with previous reports
[34] we have verified that the S. aureus tagO null mutant is as
resistant to lysozyme as the parental strain. The tagO null
mutant only becomes susceptible to lysozyme when an
additional mutation in the oat gene, encoding a protein
responsible for PG O-acetylation, is introduced (data not
shown). Most importantly, injection of S. aureus tagO null
mutant into PGRP-SA mutant flies was lethal, indicating that
(percentage of WTA produced by each strain was quantified as the signal intensity of bands of WTA in the native gels, and it was normalized against
the corresponding value for the wild type – considered as 100%): RNDtagO pMAD lacks WTA; RNDtagO ptagO produces 90% WTA relative to the
parental RN4220; and RNDtagO ptagOG152A produces 24% WTA relative to the parental RN4220 strain. Wild type flies succumb successively to
infection as the levels of WTA increase (log-rank test, P,0.05), likewise for the PGRP-SD mutant. In addition, survival of wild type and PGRP-SD mutant
flies increasingly separates for each of the bacterial mutants: wild type versus PGRP-SD, P=0.2452 (log-rank test, RNDtagO pMAD); P=0.0053
(RNDtagO ptagOG152A); P=0.0001 (RNDtagO ptagO). For all infections, PGRP-SA mutant flies succumb equally to infection (log-rank test, P.0.05).
doi:10.1371/journal.ppat.1002421.g005
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the haemolymph of flies if undeterred by PGRP-SA.
3. The possibility that PGRP-SA is responsible for directly killing
bacteria lacking WTA was also ruled-out as there was no
alteration in the growth rate of S. aureus tagO null mutant when
grown in the presence of recombinant PGRP-SA (data not
shown). PGRP-SA is believed to be non-lytic [35]. Neverthe-
less, this is a working hypothesis and has not been formally
proven. In contrast, an unusual L,D-carboxypeptidase activity
has been observed towards PG of some Gram-negative bacteria
[36]. At the present moment, we cannot exclude that a protein
existing in the haemolymph is capable of mediating killing of S.
aureus tagO in complex with PGRP-SA. In accordance to the
latter hypothesis we have previously shown that PGRP-SA
enhances the weak endomuramidase activity of GNBP1 for PG
of M luteus, the cell wall of which (like tagO), is devoid of WTA
[37].
4. The possibility that the absence of WTA could turn S. aureus
bacteria more susceptible to AMPs (produced as a consequence
of the recognition of an invading pathogen) was also tested.
Injection of S. aureus tagO null mutant into mutant flies affected
in the ability to produce AMPS, such as Dif
1-key
1, spz
rm7 and
spz
1 was not lethal to the flies, indicating that the S. aureus tagO
null mutant bacteria were being eliminated in a way that was
dependent on recognition by PGRP-SA but not dependent
upon activation of the production of AMPs (Figure S6). At the
moment we are unable to identify how Drosophila flies are killing
invading S. aureus tagO null mutant bacteria. It is possible that
bacteria, upon recognition by PGRP-SA, are more easily
phagocytised or that, as in Tenebrio molitor [38], PGRP-SA
binding recruits the local melanization cascade, triggering such
a response.
Our results underline an important aspect of pathogen
recognition by the host, which remains relatively unexplored.
Namely, how does the host recognition machinery respond to
changes in the surface of bacteria? Here we manipulated the
amount of WTA on the cell surface of S. aureus. Previously, two
host PGRPs, PGRP-SA and PGRP-SD were found to be involved
in recognition of wild type S. aureus [14,15]. We found here that
when WTA were genetically removed, the requirement for PGRP-
SD was abolished. Flies deficient for PGRP-SD had estimated
survival probabilities comparable to wild type flies following
infection by S. aureus DtagO or DtagOptagO
D87/D88A. When a small
amount of WTA was left on the surface through the residual
activity of the S. aureus DtagOptagO
G152A then PGRP-SD mutants
were less able to survive infection. However this sensitivity was not
as pronounced as when infected with S. aureus DtagOptagO, the
strain with reconstituted wild type levels of WTA. Previous studies
have established that PGRP-SD does not bind Gram-positive Lys-
type PG [14,39]. However, in its presence, PGRP-SA was able to
bind substantially better to cell wall from S. aureus and S.
saprophyticus [14]. Our results, combined with the latter observa-
tion, support a role for PGRP-SD in neutralizing the effect of
WTA obstructing access to PG. The alternate hypothesis that
PGRP-SD may directly recognize WTA, and is therefore not
necessary when flies are infected with bacteria that lack teichoic
acids, is also a possibility.
The role of teichoic acids in concealing PG at the surface of
Gram-positive bacteria may be also effective in preventing
recognition by innate immune sensors of other organisms. It is
now established that insect PGRPs have mammalian homologues
and mice and humans express four genes encoding members of
this family [35]. Our results correlate with data, which attributed a
significantly reduced virulence of tagO mutants in cotton rat nasal
colonisation model [40] as well as a mouse endophthalmitis model
[41] and suggest a mechanism for how this may happen: absence
of teichoic acids may render PG at the bacteria surface more
exposed to the host immune system.
Materials and Methods
Microbial and fly strains
Isogenic wild type flies (Bloomington #25174) were used as the
wild type control. For the survival and bacterial Colony Forming
Unit (CFU) experiments, and DD1 flies for assaying Drs levels
visually or via qPCR; the latter carries a Drs-GFP and a Diptericin-
lacz reporter [42]. The PGRP-SA and PGRP-SD mutant
backgrounds are, respectively: flies with the semmelweis mutation
in PGRP-SA [16] and a 1499 bp deletion in PGRP-SD (PGRP-SD
D3)
[15]. The spz
rm7 [43] and spz
1 [44] Toll pathway mutant
backgrounds, and the Dif
1-key
1 [45] Toll-IMD pathways double
mutant background, were used to assess survival of flies deficient
for AMPs. All fly stocks were reared at 25uC. Bacterial strains are
listed below. S. aureus strains were grown in tryptic soy broth
medium (TSB; Difco) supplemented with antibiotic (erythromycin
10 mg/ml; Sigma-Aldrich) when required. E. faecalis was grown in
brain heart infusion medium (BHI; Fluka). M. luteus was grown in
Luria-Bertani medium (LB; Difco). Bacteria were plated from -
80uC stocks every 7 days Growth of all bacteria cultures were done
at 30uCa sS. aureus mutants impaired in the synthesis of teichoic
acids are thermosensitive [46].
S. aureus strains
NCTC8325-4 (S. aureus reference strain from R. Novick);
NCTCDtagO (NCTC8325-4 tagO null mutant [29]); RN4220
(Restriction deficient derivative of S. aureus NCTC8325-4 that can
be electroporated); RNDtagO (RN4220 tagO null mutant [29]);
RNDtagOpMAD (RNDtagO transformed with pMAD [29]– shuttle
vector with a thermosensitive origin of replication for Gram-
positive bacteria); RNDtagO ptagO (RnDtagO transformed with
ptagO [29]); RNDtagO ptagO
D87A/D88A (RNDtagO transformed
ptagO
D87A/D88A [29]); RNDtagO ptagO
G152A;R N DtagO trans-
formed with ptagO
G152A, [29]); RNDdltABCD (RN4220 dltABCD
null mutant [29]); RNDdltABCD (RN4220 dltABCD null mutant
[29]); RNDdltA (RN4220 dltA null mutant, this study). M. luteus
strain: DMS20030 [47]; E. faecalis strain: JH2-2 [48]; B. subtilis
strain MB24 [49].
Construction of the RNDdltA null mutant
To delete the dltA gene from the chromosome of S. aureus
RN4220 we started by amplifying two 0.55 Kb DNA fragments
from the genome of S. aureus NCTC 8325-4 strain, corresponding
to the upstream (primers 59-AGATCTgaatgtatatatttgcgctgatg-39
and 59-gtaaaatcaccatatggaatcatattaagtctccctcattagaactc-39) and
downstream (primers 59- gagttctaatgagggagacttaatatgattccatatggt-
gattttac-39 and 59-GAATTCcgaaacgtttgtaacgatcg-39) regions of
the dltA gene. The two fragments were joined by overlap PCR
using primers P33 and P36 and the resulting PCR product was
digested with BglII and EcoRI and cloned into the pMAD vector,
producing the plasmid pDdltA. This plasmid was sequenced and
electroporated into S. aureus RN4220 strain. Insertion and excision
of pDdltA into the chromosome of RN4220 was performed as
previously described [29] with the exception of the incubation
temperature after excision of the plasmid, which was 30uC (instead
of 43uC) due to the thermosensitive nature of the cells lacking D-
alanylation. Deletion of dltA was confirmed by PCR, and the
resulting strain was named RNDdltA.
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Overnight 10 ml cultures of bacteria were washed and
resuspended in an equal volume of sterile phosphate buffered
saline (PBS), and further diluted 1/1000. Healthy looking adult
flies from uncrowded bottles, 2–4 days old, were injected in the
thorax with 32 nl of a bacterial cell suspension or PBS using a
nanoinjector (Nanoject II, Drummond Scientific). For determina-
tion of CFUs, injected flies (6 females) were crushed immediately
in media appropriate for the bacteria injected and the homoge-
nates were diluted and plated on tryptic soy agar-media (TSA).
The plates were incubated at 30uC for 20–30 hours and the
colony forming units (CFUs) per fly were measured by counting
the number of colonies on each plate, the CFUs per fly were used
to adjust the initial dose of bacteria injected to approximately
100 CFUs per fly. For the time course (0, 6, 17 hours)
determination of CFUs, each value represents an arithmetic
average derived from three biological repeat experiments (n=3).
Flies for survival and PGRP-SA mutant rescue assays were
inoculated concurrently with those for determining CFUs, with ten
or fifteen flies of each sex injected per bacteria-fly strain
combination (or PBS-fly strain); each combination being repeated
independently three times (n=3). Following injection, flies were
transferred to 30uC and survival assessed every 24 hours over a
period of 3 days. Since the trends in survival were the same (i.e.
survival curves were positioned similarly relative to one another)
for each independent biological repeat, the data for each bacteria-
fly strain combination was added (n=60orn=90) and estimates
of survival curves constructed. Flies injected with PBS were mostly
unaffected for all fly backgrounds.
Purification of recombinant rPGRP-SA and mCherry-
PGRP-SA from E.coli
A truncated version of PGRP-SA (in which the N-terminal
sorting sequence was replaced with a T7 tag, and a poly-histidine
tag was added to the C-terminus) was expressed in E. coli and
purified using cobalt affinity resin (Talon; BD Biosciences) under
denaturing conditions. A mCherry tagged derivative, mCherry-
PGRP-SA was produced using the same procedure. Proteins were
stored in 20 mM Tris-HCl pH 8.0 and 150 mM NaCl.
Protein functionality assays
Functionality assays of the rPGRP-SA and mCherry-PGRP-SA
proteins were performed as previously described [14]. Drs-GFP
expression was monitored after 24 hours of the M. luteus infection
through the production of fluorescent signal produced by the
infected flies; and by qPCR using as template RNA extracted from
6 infected female flies, similar to what was previously described
[50].
Purification of peptidoglycan
Peptidoglycan was prepared from exponentially growing
cultures of S. aureus, B. subtilis, M. luteus, and E. faecalis as previously
described [13].
PGRP-SA-peptidoglycan co-precipitation assay
50 mg of recombinant PGRP-SA was incubated with 0.2 mg of
peptidoglycan and 17 mg of BSA (New England Biolabs) in
20 mM Tris-HCL pH 8.0 and 300 mM NaCl in a final volume of
300 ml. Incubation was at 25uC with agitation for 30 minutes.
Peptidoglycan and co-precipitated proteins were harvested by
centrifugation, washed twice with 20 mM Tris-HCl pH 8.0,
300 mM NaCl and then resuspended in 16SDS loading buffer,
boiled for 5 minutes and run on 12% SDS PAGE mini gels. An
aliquot of the supernatant, representing unbound protein, was also
run. Gels were stained with Coommasie stain, destained and
imaged using an ImageScanner (Amersham Biosciences/GE
Healthcare). Quantifications of bands performed using ImageJ
software [51]; each value represents an arithmetic average derived
from three biological repeat experiments (n=3).
mCherry-PGRP-SA binding to bacteria
Bacteria were grown to mid-exponential phase. Washed cell
cultures in PBS (500 ml) were incubated with 50 ml of mCherry-
PGRP-SA (2 mg/ml in 150 mM NaCl, 20 mM Tris pH 8.0) for 5
minutes on ice. The cells were washed twice with PBS and
harvested at 4uC (3000 rpm, 10 minutes). Finally the bacteria were
resuspended in 20 ml PBS. A drop of this culture was placed on a
PBS, 1% agarose slide and visualised. Images were obtained using
a Zeiss Axio ObserverZ1 microscope equipped with a Photo-
metrics CoolSNAP HQ2 camera (Roper Scientific using Meta-
morph software, Meta Imaging series 7.5) and analyzed using
ImageJ software.
WTA extraction
WTA were extracted by alkaline hydrolysis from overnight
cultures were analyzed by native polyacrylamide gel electropho-
resis and visualized by combined alcian blue silver staining, as
previously described [52]. ImageJ software [51] was used to
quantify the percentage of WTA produced by each strain as
previously described [29]. The signal intensity of each lane was
quantified and normalized against the corresponding value for the
wild type (considered as 100%).
WTA inhibition
Tunicamycin minimum inhibitory concentration (MIC) assays
were performed as previously described [28]. Overnight cultures
of bacteria were grown in antibiotic free medium or in the
presence of a subinhibitory concentration of tunicamycin (0.8 ug/
ml for E. faecalis –1 7 6less than the MIC - and 0.4 ug/ml for S.
aureus and S. saprophyticus –3 2 6 less than MIC), that doesn’t
interfere with the bacterial growth rate. For mCherry-PGRP-SA
binding assays, overnight cultures were diluted 1:100 into fresh
medium, with or without tunicamycin at the appropriate
concentration, and were grown until mid-exponential phase. For
survival experiments, we used S. aureus overnight culture grown
with tunicamycin as above described.
Data analysis
As nonparametric tests lack statistical power with small samples,
when required, data sets with three biological repeats (n=3) were
transformed to give a normal distribution (Lilliefors test, P.0.05)
and then checked for equal variance (Levene’s test, P.0.05);
subsequently, data was analysed using parametric tests.
Binding assays
Data for the PGRP-SA-peptidoglycan co-precipitation assay
was normal with equal variance, thus not transformed; One-way
ANOVA was applied to the data. For the mCherry-PGRP-SA
binding to bacteria assays data (n=50) was non-normal but with
equal variance, therefore nonparametric Kruskal-Wallis test
followed by Dunn’s multiple comparison was applied.
CFUs
The complete CFU data set exhibited neither normality nor
equal variance, and attempts to rectify this by transforming the
data failed. Therefore, the data was separated into 6 groups, which
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(Box-Cox returns a l number, where a transformed data-point =
data-point
l –1 / l) to give a normal distribution with equal
variance, and statistical analysis performed as described. Firstly,
for each bacterial strain (groups 1–3, graphical representations not
shown), Repeated Measures Two-way ANOVA was used to look
for differences over time and between the fly backgrounds.
However, due to interactions between these two factors, Repeated
Measures One-way ANOVA with 95% Tukey’s HSD Intervals
was used to look for differences over time for each particular
bacteria strain and fly background combination (i.e. 9 separate
tests, data for each was normally distributed with equal variance).
Secondly, at each time point (groups 4–6, Figure 3), Two-Way
ANOVA was used to look for differences between the bacterial
strains and between the fly backgrounds; where there was an
interaction between these two factors, One-way ANOVA with
95% Tukey’s HSD Intervals was used to look for differences
between the fly backgrounds for a particular bacterial strain.
Fly survival
Estimated survival curves were constructed from the raw data
sets and the Log-rank (Mantel-Cox) test used to determine
statistical significance between the curves. For clarity in display,
95% confidence intervals have been omitted from the graphs. All
data was plotted and analyzed using GraphPad Prism 5
(GraphPad Software, Inc.) or MATLAB R2009a.
Supporting Information
Figure S1. Recombinant PGPR-SA proteins rescue Drs
expression in D. melanogaster. D. melanogaster recombinant
PGRP-SA proteins were produced in E. coli, except Sf9 rPGRP-
SA, which was produced in an insect cell line. Flies carrying a Drs-
GFP reporter were firstly injected with either 10 ng of a
recombinant PGRP-SA (+), 10 ng of the fluorescent mCherry-
tag (+), or an equivalent volume of sterile PBS when protein was
not injected (PBS); after 2 hours the same flies were infected with
M. luteus. (A) Drs-GFP expression was observed after 24 hours (Drs-
GFP), and likewise mCherry fluorescence (mCherry). DD1 flies
were used as a wild type control for Drs-GFP expression upon
infection; all recombinant PGRP-SA proteins rescued Drs-GFP
expression in the PGRP-SA mutant background, whereas the
mCherry-tag or sterile PBS did not. (B) The pooled Drs mRNA
levels (normalised to the non-immune ribosomal gene RP49) from
12 female flies was determined 24 hours post-infection via qPCR.
For each fly background, the Drs mRNA levels induced by M.
luteus were expressed as fold-change relative to the PBS injection
(comparative CT method). Each column represents the mean
value for three independent sets of injection (n=3), and the error
bars 95% confidence intervals. One-Way ANOVA and 95%
Tukey HSD Intervals were used to analyse the data for PGRP-SA
mutant flies: significant differences were not found between flies
injected with PBS, M. luteus, or with only the recombinant
proteins. However, the combination of a recombinant PGRP-SA
with M. luteus greatly enhanced the levels of Drs mRNA (P,0.05).
(TIF)
Figure S2. Substrates used in this study. (A) Substrates
used in this study. A schematic representation of the different
substrates used in binding reactions in this study. The surface of
live cells is very complex and consists of Peptidoglycan (PG) with
attached proteins (purple ovoids), large polymers (such as teichoic
acids, red spheres) and other covalent modifications (including O-
acetylation, blue triangles). The surface of live cells will also be
influenced by the presence of other molecules that are not
covalently attached to the PG such as lipoteichoic acids (green
spheres) which are anchored in the cell membrane and extra
cellular proteins which are not covalently linked to the surface or
are anchored in the cell membrane (purple stars and purple shapes
in the membrane). It should also be noted that the surfaces of live
cells are constantly undergoing remodelling processes and that the
PG will be growing and dividing. Cell wall (CW) is produced from
live cells by a treatment that subjects the cells to mechanical stress
followed by boiling in detergent and treatment with proteases,
DNases and RNases. CW consists of PG with covalently attached
modifications such as teichoic acids and O-acetylation but free of
protein, membrane and nucleic acids. PG is produced from CW
by treatment with hydrofluoric acid that removes teichoic acids
and O-acetylation, leaving just the naked PG mesh. CW and PG
are metabolically inert, the structures should not change with time.
(B) PGRP-SA co-precipitation assay in the presence of CW and
PG. Binding of PGRP-SA to CW produced from NCTC8325-4 is
very low (left panel, lane 4). On the other hand, binding of PGRP-
SA to PG produced from NCTC8325-4 is high (right panel, lane
4). The difference between CW and PG is the presence or absence
of O-acetyl groups and teichoic acids. Removal of these from CW
makes the resulting PG a far better substrate for binding of PGRP-
SA. (C) PG type and structure of the repeating unit of teichoic
acids found in the strains used in this study. Note that the S.
saphrophyticus strain used here (ATCC 15305) has a similar or
identical teichoic acid composition to S.aureus. Most other strains
of S. saprophyticus contain a teichoic acid based around a glycerol
repeating unit. This glycerol repeating unit is modified by the
addition of glucose.
(TIF)
Figure S3. Absence of WTA, rather than reduced cross-
linking or D-alanylation of WTA, enhances PGRP-SA
binding to the surface of S. aureus. (A) Secretion of
hemolysins was assayed on TSA blood agar plates to determine
the agr phenotype of the parental S. aureus strains, NCTC8325-4
and RN4220, used in this study. The formation of an inner halo of
clearing in the plates is due to the action of the d-hemolysin, only
produced by agr positive strains. According to this NCTC8325-4 is
an agr positive (+) strain while RN4220 is an agr negative (-) strain.
(B) Growth curves of S. aureus wild type and mutants strains in
TSB. Overnight cultures were diluted to a starting optical density
(OD600) of 0.05, and absorbance measurements were taken every
30 minutes. Shown are representative growth curves of experi-
ments conducted in triplicate; generation times shown as
arithmetic averages with standard deviations in the table were
calculated during the exponential phase of the growth.
NCTCDtagO and NCTCDpbpD showed similar generation times
to the NCTC8325-4 wild type strain. (C) Exponentially growing
cells of NCTC8325-4, NCTCDtagO and NCTCDpbpD were
incubated with mCherry-PGRP-SA. In addition to lacking
WTA, NCTCDtagO produces a PG with a reduced cross-linking,
similar to that seen with NCTCDpbpD. The fluorescent derivative
of PGRP-SA protein was not able to the surface of NCTCDpbpD
bacteria that produces teichoic acids at their surface. Exponential
phase cells of RN4220 (a laboratory strain that is agr defective),
RNDtagO and RNDdltABCD were also incubated with the protein.
The RNDdltABCD is a mutant strain whose WTA lacks D-alanine
residues. The fluorescent derivative of PGRP-SA protein was not
able to the surface of RNDdltABCD bacteria that produces teichoic
acids with no D-alanines at their surface. Grey panels are phase-
contrast images of bacterial cells (white scale bar represents 1 mm);
black panels mCherry-PGRP-SA binding. Images also show that
mcherry-PGRP-SA bound strongly to tagO null mutants con-
structed in both NCTC8325-4 (agr positive) and RN4220 (agr
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infected with S. aureus agr positive (NCTC8325-4 and
NCTCDtagO) and negative strains (RN4220 and RNDtagO). Flies
were infected with ,100 bacterial cells and fly survival was
assessed every 24 hours over 3 days. S. aureus RN4220 strain with
agr negative phenotype is not affected in the ability to kill
drosophila flies.
(TIF)
Figure S4. PGRP-SA mutant flies survive infection by S.
aureus strains defective in the D-alanylation of WTA.
The dltABCD operon encode proteins involved in the D-
alanylation of WTA. Deletion of dltA, or of the dltABCD operon,
result in bacteria that produce D-Alanine free WTA. With all
backgrounds, more than 80% of flies survived infection by
RNDdltABCD or RNDdltA; all curves being statistically inseparable
(log-rank, P.0.05). Survival outcomes with the parental RN4220
strain are similar to those seen with NCTC8325-4.
(TIF)
Figure S5. Survival dynamics prior to 24 hours post-
infection. As previously performed, the given fly strains (n=90)
were infected with either S. aureus NCTC8325-4 or NCTCDtagO
strains, and survival monitored every 6 hours. This revealed that
PGRP-SA and GNBP1 mutants succumb almost completely to
NCTC8325-4 infection after approximately 18 hours, whereas for
NCTCDtagO, this occurs after 24 hours.
(TIF)
Figure S6. Flies severely compromised in AMP produc-
tion are able to survive upon infection with S. aureus
lacking WTA. To assess the contribution of AMPs with regards
to determining how flies survive infection with NCTC8325-4 or
NCTCDtagO, flies compromised in their ability to produce AMPs
(PGRP-SA, Dif-key, spz
1 and spz
rm7) were infected (,100 cells per
fly) and survival recorded every 24 hours over 3 days. For each fly
background – except wild type – survival curves were statistically
inseparable for flies infected with NCTC8325-4 (log-rank test,
P.0.05). Flies affected in the production of AMPs succumbed
strongly to infection with wild type bacteria NCTC8325-4 by
72 hours, whereas wild type flies survived up to ,55%. When
infected with NCTCDtagO, survival curves for each fly background
were statistically different from the PGRP-SA mutant flies (log-
rank test, P.0.05). PGRP-SA mutant flies succumbed to infection,
whereas the rest of the mutants containing functional PGRP-SA
but affected in the ability to produced AMPs survived up to more
than 60% by 72 hours.
(TIF)
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